[1]
A. Ownis, “CRISPR-dCas9-Mediated Epigenetic Reactivation of LRIG1 Suppresses Oncogenic Signaling in Triple-Negative Breast Cancer”, AJBAS, vol. 8, no. 1, Jan. 2026.